- Home
- GNSS vs ANIX Comparison
GNSS vs ANIX Comparison
Compare GNSS & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- ANIX
- Stock Information
- Founded
- GNSS 1992
- ANIX 1982
- Country
- GNSS United States
- ANIX United States
- Employees
- GNSS N/A
- ANIX N/A
- Industry
- GNSS Consumer Electronics/Appliances
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- ANIX Health Care
- Exchange
- GNSS Nasdaq
- ANIX Nasdaq
- Market Cap
- GNSS 112.9M
- ANIX 95.7M
- IPO Year
- GNSS N/A
- ANIX 1987
- Fundamental
- Price
- GNSS $2.22
- ANIX $4.47
- Analyst Decision
- GNSS Strong Buy
- ANIX Strong Buy
- Analyst Count
- GNSS 1
- ANIX 3
- Target Price
- GNSS $5.75
- ANIX $9.00
- AVG Volume (30 Days)
- GNSS 286.6K
- ANIX 273.7K
- Earning Date
- GNSS 08-14-2025
- ANIX 09-10-2025
- Dividend Yield
- GNSS N/A
- ANIX N/A
- EPS Growth
- GNSS N/A
- ANIX N/A
- EPS
- GNSS N/A
- ANIX N/A
- Revenue
- GNSS $30,470,000.00
- ANIX N/A
- Revenue This Year
- GNSS $90.97
- ANIX N/A
- Revenue Next Year
- GNSS $75.75
- ANIX N/A
- P/E Ratio
- GNSS N/A
- ANIX N/A
- Revenue Growth
- GNSS 8.95
- ANIX N/A
- 52 Week Low
- GNSS $1.46
- ANIX $2.07
- 52 Week High
- GNSS $4.04
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- GNSS 48.28
- ANIX 65.69
- Support Level
- GNSS $2.11
- ANIX $4.21
- Resistance Level
- GNSS $2.32
- ANIX $4.98
- Average True Range (ATR)
- GNSS 0.15
- ANIX 0.32
- MACD
- GNSS -0.04
- ANIX 0.09
- Stochastic Oscillator
- GNSS 22.92
- ANIX 70.12
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.